The effects of short-term propofol and dexmedetomidine on lung mechanics, histology, and biological markers in experimental obesity

Anesthesia and Analgesia

Volumn 122, Issue 4, 2016, Pages 1015-1023

  Heil, Luciana Boavista Barros ^a   Santos, Cíntia L ^a   Santos, Raquel S ^a   Samary, Cynthia S ^a   Cavalcanti, Vinicius C M ^a   Araújo, Mariana M P N ^a   Poggio, Hananda ^a   De A Maia, Lígia ^a   Trevenzoli, Isis Hara ^a   Pelosi, Paolo ^b   Fernandes, Fatima C ^a   Villela, Nivaldo R ^a,c   Silva, Pedro L ^a   Rocco, Patricia R M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF GENOA   (Italy)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CATALASE; CHOLESTEROL; DEXMEDETOMIDINE; GLUTATHIONE PEROXIDASE; INSULIN; INTERLEUKIN 6; LEPTIN; PROPOFOL; THIOPENTAL; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; BRONCHOCONSTRICTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET INDUCED OBESITY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; HISTOLOGY; LEAN BODY WEIGHT; LUNG MECHANICS; LUNG PARENCHYMA; LUNG TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT; ADVERSE EFFECTS; ANIMAL; BREATHING MECHANICS; DRUG EFFECTS; LUNG; METABOLISM; OBESITY; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; BIOMARKERS; DEXMEDETOMIDINE; LUNG; MALE; OBESITY; PROPOFOL; RATS; RATS, WISTAR; RESPIRATION, ARTIFICIAL; RESPIRATORY MECHANICS; TREATMENT OUTCOME;

EID: 84952684324     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001114     Document Type: Article

References (50)

1. Mraz M, Haluzik M, The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014 222 R113 27
2. Hotamisligil GS, Inflammation and metabolic disorders. Nature 2006 444 860 7
3. Wani S, Azar R, Hovis CE, Hovis RM, Cote GA, Hall M, Waldbaum L, Kushnir V, Early D, Mullady DK, Murad F, Edmundowicz SA, Jonnalagadda SS, Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. Gastrointest Endosc 2011 74 1238 47
4. Sprung J, Whalley DG, Falcone T, Warner DO, Hubmayr RD, Hammel J, The impact of morbid obesity, pneumoperitoneum, and posture on respiratory system mechanics and oxygenation during laparoscopy. Anesth Analg 2002 94 1345 50
5. Gaszynski T, Gaszynska E, Szewczyk T, Dexmedetomidine for awake intubation and an opioid-free general anesthesia in a superobese patient with suspected difficult intubation. Drug Des Devel Ther 2014 8 909 12
6. Takemoto Y, Dose effects of propofol on hemodynamic and cytokine responses to endotoxemia in rats. J Anesth 2005 19 40 4
7. Yeh CH, Cho W, So EC, Chu CC, Lin MC, Wang JJ, Hsing CH, Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1alpha expression. Br J Anaesth 2011 106 590 9
8. Vasileiou I, Kalimeris K, Nomikos T, Xanthopoulou MN, Perrea D, Agrogiannis G, Nakos G, Kostopanagiotou G, Propofol prevents lung injury following intestinal ischemia-reperfusion. J Surg Res 2012 172 146 52
9. Chen HI, Hsieh NK, Kao SJ, Su CF, Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats. Crit Care Med 2008 36 1214 21
10. Eames WO, Rooke GA, Wu RS, Bishop MJ, Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology 1996 84 1307 11
11. An K, Shu H, Huang W, Huang X, Xu M, Yang L, Xu K, Wang C, Effects of propofol on pulmonary inflammatory response and dysfunction induced by cardiopulmonary bypass. Anaesthesia 2008 63 1187 92
12. Özkan D, Akkaya T, Yalcindag A, Hanci T, Gönen E, Gümüs H, Delibas N, Propofol sedation in total knee replacement: effects on oxidative stress and ischemia-reperfusion damage. Anaesthesist 2013 62 537 42
13. Yamakage M, Iwasaki S, Satoh JI, Namiki A, Inhibitory effects of the alpha-2 adrenergic agonists clonidine and dexmedetomidine on enhanced airway tone in ovalbumin-sensitized guinea pigs. Eur J Anaesthesiol 2008 25 67 71
14. Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H, Dose-And time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth 2008 22 221 8
15. Wu Y, Liu Y, Huang H, Zhu Y, Zhang Y, Lu F, Zhou C, Huang L, Li X, Zhou C, Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/NF-κB pathway. Mediators Inflamm 2013 2013 562154
16. Cavalcanti V, Santos CL, Samary CS, Araújo MN, Heil LB, Morales MM, Silva PL, Pelosi P, Fernandes FC, Villela N, Rocco PR, Effects of short-Term propofol and dexmedetomidine on pulmonary morphofunction and biological markers in experimental mild acute lung injury. Respir Physiol Neurobiol 2014 203 45 50
17. Tasdogan M, Memis D, Sut N, Yuksel M, Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth 2009 21 394 400
18. Archer DP, Roth SH, Low concentrations of pentobarbital enhance excitability of rat hippocampal neurons. Anesth Analg 2007 105 993 7
19. Lukaski HC, Hall CB, Marchello MJ, Siders WA, Validation of dual x-ray absorptiometry for body-composition assessment of rats exposed to dietary stressors. Nutrition 2001 17 607 13
20. Baydur A, Behrakis PK, Zin WA, Jaeger M, Milic-Emili J, A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis 1982 126 788 91
21. Weibel ER, Gil J, Morphometry: stereological theory and pratical methods. In: Models of Lung Disease-Microscopy and Structural Methods 1990 New York Marcel Dekker 199 247
22. Abreu SC, Antunes MA, Maron-Gutierrez T, Cruz FF, Ornellas DS, Silva AL, Diaz BL, Ab'Saber AM, Capelozzi VL, Xisto DG, Morales MM, Rocco PR, Bone marrow mononuclear cell therapy in experimental allergic asthma: intratracheal versus intravenous administration. Respir Physiol Neurobiol 2013 185 615 24
23. Akamine R, Yamamoto T, Watanabe M, Yamazaki N, Kataoka M, Ishikawa M, Ooie T, Baba Y, Shinohara Y, Usefulness of the 5' region of the cDNA encoding acidic ribosomal phosphoprotein P0 conserved among rats, mice, and humans as a standard probe for gene expression analysis in different tissues and animal species. J Biochem Biophys Methods 2007 70 481 6
24. Amato MC, Giordano C, Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol 2014 2014 730827
25. Mancuso P, Obesity and lung inflammation. J Appl Physiol 2010 108 722 8
26. Burburan SM, Silva JD, Abreu SC, Samary CS, Guimarães IH, Xisto DG, Morales MM, Rocco PR, Effects of inhalational anaesthetics in experimental allergic asthma. Anaesthesia 2014 69 573 82
27. Aantaa R, Tonner P, Conti G, Longrois D, Mantz J, Mulier JP, Sedation options for the morbidly obese intensive care unit patient: a concise survey and an agenda for development. Multidiscip Respir Med 2015 10 8
28. Ouedraogo N, Roux E, Forestier F, Rossetti M, Savineau JP, Marthan R, Effects of intravenous anesthetics on normal and passively sensitized human isolated airway smooth muscle. Anesthesiology 1998 88 317 26
29. Brown RH, Wagner EM, Mechanisms of bronchoprotection by anesthetic induction agents: propofol versus ketamine. Anesthesiology 1999 90 822 8
30. Pedersen CM, The effect of sedation with propofol on postoperative bronchoconstriction in patients with hyperreactive airway disease. Intensive Care Med 1992 18 45 6
31. Brown RH, Greenberg RS, Wagner EM, Efficacy of propofol to prevent bronchoconstriction: effects of preservative. Anesthesiology 2001 94 851 5
32. Nishiyama T, Propofol results in higher incidence of bronchoconstriction in allergic patients. Med Arch 2013 67 168 70
33. Rieschke P, LaFleur BJ, Janicki PK, Effects of EDTA-And sulfite-containing formulations of propofol on respiratory system resistance after tracheal intubation in smokers. Anesthesiology 2003 98 323 8
34. Dewachter P, Mouton-Faivre C, Emala CW, Beloucif S, Case scenario: bronchospasm during anesthetic induction. Anesthesiology 2011 114 1200 10
35. Eder K, Baffy N, Falus A, Fulop AK, The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009 58 727 36
36. Williams AS, Chen L, Kasahara DI, Si H, Wurmbrand AP, Shore SA, Obesity and airway responsiveness: role of TNFR2. Pulm Pharmacol Ther 2013 26 444 54
37. Fried SK, Bunkin DA, Greenberg AS, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998 83 847 50
38. Nguyen T, Nioi P, Pickett CB, The Nrf2-Antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009 284 13291 5
39. Comhair SA, Erzurum SC, Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 2002 283 L246 55
40. Okuno Y, Matsuda M, Kobayashi H, Morita K, Suzuki E, Fukuhara A, Komuro R, Shimabukuro M, Shimomura I, Adipose expression of catalase is regulated via a novel remote PPARgamma-responsive region. Biochem Biophys Res Commun 2008 366 698 704
41. van der Poll T, The remarkable career of leptin: from antidote to obesity to mediator of lung inflammation. Crit Care Med 2014 42 490 2
42. Jensen AG, Dahlgren C, Eintrei C, Propofol decreases random and chemotactic stimulated locomotion of human neutrophils in vitro. Br J Anaesth 1993 70 99 100
43. O'Donnell NG, McSharry CP, Wilkinson PC, Asbury AJ, Comparison of the inhibitory effect of propofol, thiopentone and midazolam on neutrophil polarization in vitro in the presence or absence of human serum albumin. Br J Anaesth 1992 69 70 4
44. Wang ZX, Huang CY, Hua YP, Huang WQ, Deng LH, Liu KX, Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial. Br J Anaesth 2014 112 1055 64
45. Xiang H, Hu B, Li Z, Li J, Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Inflammation 2014 37 1763 70
46. Goyal R, Singhai M, Faizy AF, Glutathione peroxidase activity in obese and nonobese diabetic patients and role of hyperglycemia in oxidative stress. J Midlife Health 2011 2 72 6
47. Mathy-Hartert M, Deby-Dupont G, Hans P, Deby C, Lamy M, Protective activity of propofol, Diprivan and intralipid against active oxygen species. Mediators Inflamm 1998 7 327 33
48. Chatterjee S, Ganini D, Tokar EJ, Kumar A, Das S, Corbett J, Kadiiska MB, Waalkes MP, Diehl AM, Mason RP, Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-Alcoholic steatohepatitis. J Hepatol 2013 58 778 84
49. Salo M, Pirttikangas CO, Pulkki K, Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro. Anaesthesia 1997 52 341 4
50. Love L, Cline MG, Perioperative physiology and pharmacology in the obese small animal patient. Vet Anaesth Analg 2015 42 119 32